Sight Sciences releases cost-utility analysis comparing TearCare and cyclosporine 0.05% in dry eye
TearCare is associated with greater health utility over time but also resulted in significant cost savings compared with CsA
4DMT announces positive results from SPECTRA trial evaluating 4D-150 in patients with DME
4D-150 is an investigational agent designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and anti-VEGF-C) from the retina with a single, safe, intravitreal injection.
Alcon announces US launch of Tryptyr (acoltremon ophthalmic solution) 0.003% for dry eye disease
The solution was approved by the US Food and Drug Administration in late May 2025.
Raytone Biotech treats first patient in clinical trial of RTP-008 for dry eye disease
RTP-008 features sustained immunosuppressant delivery for long-term therapeutic effects.
ASRS 2025: A look at secondary scleral-sutured toric intraocular lens for astigmatic correction in the absence of capsular support
ASRS 2025: Phase 1/2 study update on OCU-410 for geographic atrophy
Jay Chhablani, MD, presented the phase 1/2 clinical trial data for OCU410, at the 2025 annual meeting of the American Society of Retina Specialists.
Q&A: The potential impact of vitamin D on retinal surgery
Steven D. Ness, MD, discusses his research on vitamin D's role in reducing complications after retinal surgery at ASRS 2025.
ASRS 2025: 24-Month results of the phase 2 SKYLINE trial
ASRS 2025: Post-op day 0 vs day 1 exams
ASRS 2025: Neuro-ophthalmology: What every retina doctor needs to know
At ASRS 2025, Andrew G Lee, MD, gave key insight into the world of a neuro-ophthalmologist and why and when a retina specialist should consult a neuro-ophthalmologist
Handheld fundus camera from Optomed USA launched for use in any care setting
Optomed Lumo launches a versatile handheld fundus camera, enhancing retinal imaging accessibility in diverse healthcare settings across the US.
FDA approves Lenz Therapeutics’ VIZZ for the treatment of presbyopia
Vizz (Lenz Therapeutics) is the first and only aceclidine-based eye drop for presbyopia and is also the first daily solution to correct vision for up to 10 hours.
ASRS 2025: ASRS 2025: Suprachoroidal avoralstat stops vascular leakage in a well-established rabbit model
Q&A: Updates on faricimab for DME from ASRS 2025
Q&A: A VERONA trial update with Yasha S. Modi, MD
Yasha S. Modi, MD, discusses promising results from the VERONA study on EYP-1901, a potential treatment for diabetic macular edema.
EyePoint completes enrollment of LUGANO and LUCIA trials
EyePoint Pharmaceuticals completes enrollment for the LUCIA trial, advancing DURAVYU's potential as a new treatment for wet AMD.
Opus Genetics partners with Global RDH12 Alliance
Opus Genetics partners with the Global RDH12 Alliance to advance gene therapy for inherited retinal disease, aiming for FDA application by late 2025.
Wills Eye Hospital names Julia A. Haller, MD, as new chief executive officer
The Eye Care Network connected with Haller to hear her vision for Wills Eye Hospital, her priorities as CEO, and what lies ahead for the field of ophthalmology.
Topcon acquires Intelligent Retinal Imaging Systems, bolstering AI-powered screenings
Integrating IRIS technologies will allow Topcon to improve retinal disease diagnostics and referrals from primary care providers.
S. Robert Levine, MD, on the DRD Cure Accelerator: A global moonshot for retinal disease
The DRD Cure Accelerator, highlighted at the CCOI-Stanford Summit, is a global initiative advancing clinical research and collaborations to eliminate vision loss from diabetic retinal disease.
Retinal microvasculature on OCTA may predict coronary artery disease risk
Japanese researchers link outdoor time to rapid increase in choroidal thickness
Phase 3 study of LUMIFY Preservative Free and LUMIFY eye drops meets primary end point
What to expect from ASRS 2025
In preparation for the American Society of Retina Specialist (ASRS) annual meeting being held in Long Beach, California, Ophthalmology spoke with Gaurav Shah MD, FASRS, Program Chair of the 2025 event.
Alcon to showcase next-gen retina tools and clinical data at ASRS annual meeting
Notably, Alcon will be providing a demo of the UNIPEXY Gas Delivery System
Bascom Palmer Eye Institute ranked as top ophthalmology hospital in US for 22nd year in a row
The annual Best Hospitals report from US News & World Report compares more than 4500 hospitals across 15 specialties and 22 procedures and conditions.
Alteogen receives positive CHMP opinion for aflibercept biosimilar, EYLUXVI
Re-Vana and Boehringer Ingelheim launch $1B collaboration to develop extended-release eye therapies
CORXEL submits NDA for LNZ100 in China for presbyopia treatment
LENZ Therapeutics previously licensed Greater China rights to CORXEL for the development and commercialization of LNZ100 in April 2022.
Alkeus Pharmaceuticals to present TEASE and SAGA study data at ASRS 2025
Discover groundbreaking findings on oral gildeuretinol's impact on Stargardt disease at the ASRS 43rd Annual Meeting in Long Beach, California.
